Avinger Inc (AVGR) - Total Assets
Based on the latest financial reports, Avinger Inc (AVGR) holds total assets worth $13.60 Million USD as of September 2024. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See AVGR total equity for net asset value and shareholders' equity analysis.
Avinger Inc - Total Assets Trend (2012–2023)
This chart illustrates how Avinger Inc's total assets have evolved over time, based on quarterly financial data.
Avinger Inc - Asset Composition Analysis
Current Asset Composition (December 2023)
Avinger Inc's total assets of $13.60 Million consist of 88.3% current assets and 11.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 38.3% |
| Accounts Receivable | $1.01 Million | 7.4% |
| Inventory | $5.30 Million | 38.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2012–2023)
This chart illustrates how Avinger Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is Avinger Inc worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Avinger Inc's current assets represent 88.3% of total assets in 2023, an increase from 86.2% in 2012.
- Cash Position: Cash and equivalents constituted 38.3% of total assets in 2023, down from 68.0% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2012.
- Asset Diversification: The largest asset category is inventory at 38.5% of total assets.
Avinger Inc Competitors by Total Assets
Key competitors of Avinger Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
|
China | CN¥12.14 Billion |
|
Vizionfocus Inc.
TW:4771
|
Taiwan | NT$6.53 Billion |
|
MEDIMI AB AK
F:79T
|
Germany | €1.70 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.32 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$272.48 Million |
|
SDI Ltd
AU:SDI
|
Australia | AU$141.20 Million |
|
Austco Healthcare Ltd
AU:AHC
|
Australia | AU$91.07 Million |
|
Trajan Group Holdings Ltd
AU:TRJ
|
Australia | AU$192.32 Million |
Avinger Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.21 | 0.85 | 1.30 |
| Quick Ratio | 0.81 | 0.55 | 0.99 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $1.98 Million | $-2.68 Million | $3.84 Million |
Avinger Inc - Advanced Valuation Insights
This section examines the relationship between Avinger Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.39 |
| Latest Market Cap to Assets Ratio | 0.11 |
| Asset Growth Rate (YoY) | -43.1% |
| Total Assets | $13.77 Million |
| Market Capitalization | $1.52 Million USD |
Valuation Analysis
Below Book Valuation: The market values Avinger Inc's assets below their book value (0.11x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Avinger Inc's assets decreased by 43.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Avinger Inc (2012–2023)
The table below shows the annual total assets of Avinger Inc from 2012 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | $13.77 Million | -43.09% |
| 2022-12-31 | $24.20 Million | -17.94% |
| 2021-12-31 | $29.48 Million | -11.18% |
| 2020-12-31 | $33.20 Million | +39.33% |
| 2019-12-31 | $23.82 Million | +0.53% |
| 2018-12-31 | $23.70 Million | +57.07% |
| 2017-12-31 | $15.09 Million | -71.83% |
| 2016-12-31 | $53.56 Million | -1.01% |
| 2015-12-31 | $54.10 Million | +118.34% |
| 2014-12-31 | $24.78 Million | -0.91% |
| 2013-12-31 | $25.01 Million | -17.53% |
| 2012-12-31 | $30.32 Million | -- |
About Avinger Inc
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to prov… Read more